These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28534298)

  • 1. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
    Czarnobaj K; Prokopowicz M; Sawicki W
    AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Materials Based on Polymeric Silica as Bone-Targeted Drug Delivery Systems for Metronidazole.
    Czarnobaj K; Prokopowicz M; Greber K
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
    Prokopowicz M
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
    Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
    Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-Activated Fibre-Like SBA-15 as Drug Carriers for Bone Diseases.
    Prokopowicz M; Żeglinski J; Szewczyk A; Skwira A; Walker G
    AAPS PharmSciTech; 2018 Dec; 20(1):17. PubMed ID: 30574669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, characterisation and in vitro studies of doxorubicin-loaded silica-polydimethylsiloxane granules.
    Prokopowicz M
    Eur J Pharm Sci; 2015 Jan; 66():10-9. PubMed ID: 25281914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
    Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate.
    Jadhav NV; Vavia PR
    AAPS PharmSciTech; 2017 Oct; 18(7):2764-2773. PubMed ID: 28353172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Design of Nanostructured Metronidazole-Loaded HPC/Oxide Xerogel Composites: Influence of the Formulation Parameters on In Vitro Characterisation.
    Czarnobaj K
    AAPS PharmSciTech; 2015 Oct; 16(5):1160-8. PubMed ID: 25716331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
    Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
    Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
    J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies.
    Prokopowicz M; Zegliński J; Gandhi A; Sawicki W; Tofail SA
    Colloids Surf B Biointerfaces; 2012 May; 93():249-59. PubMed ID: 22325320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion and release of fenbufen in mesoporous silica.
    Carriazo D; del Arco M; Fernández A; Martín C; Rives V
    J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional materials such as MCM-41÷Fe3O4÷folic acid as drug delivery system.
    Popescu S; Ardelean IL; Gudovan D; Rădulescu M; Ficai D; Ficai A; Vasile BŞ; Andronescu E
    Rom J Morphol Embryol; 2016; 57(2):483-9. PubMed ID: 27516022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro characterisation of bioactive mesoporous silica microparticles for drug delivery applications.
    Prokopowicz M; Czarnobaj K; Szewczyk A; Sawicki W
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():7-18. PubMed ID: 26706501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wet powder processing of sol-gel derived mesoporous silica-hydroxyapatite hybrid powders.
    Andersson J; Johannessen E; Areva S; Järn M; Lindén M
    J Nanosci Nanotechnol; 2006 Aug; 6(8):2438-44. PubMed ID: 17037853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.